FRMPD1 and benign prostatic hyperplasia: We then evaluated the chromatin accessibility in the promoter regions of FRMPD1, TMEM18, and ZNHIT3 using ATAC-seq data from clinical patient samples from BPH, untreated primary PCa, and locally recurrent CRPC samples.